Financings
Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms
GENX · Price
Executive Summary
- Genix Pharmaceuticals corrects the issue price of its recently closed non‑brokered private placement from $0.10 to $0.05 per Unit.
- The company issued 2,000,000 Units at the corrected price, raising total gross proceeds of $100,000.
- Each Unit includes one common share and one transferable warrant exercisable at $0.10 per Share for two years (expires 2027‑09‑04).
Key Details
- Corrected issue price: $0.05 per Unit (previously misstated as $0.10).
- Units issued: 2,000,000.
- Gross proceeds: $100,000.
- Composition of each Unit: one common share + one transferable common share purchase warrant.
- Warrant terms: right to acquire one additional share at $0.10 per Share, exercisable for two (2) years from closing; expiry date September 4, 2027.
- All other private placement terms remain unchanged.
Notable Quotes
(No direct quotes provided in the release.)